These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38020606)

  • 1. The budget impact of alteplase in the treatment of acute ischemic stroke in Egypt.
    Aref H; El Nahas N; Elsisi GH; Shokri H; Roushdy T
    Front Neurol; 2023; 14():1220615. PubMed ID: 38020606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budget impact analysis for dapagliflozin in type 2 diabetes in Egypt.
    Elsisi GH; Anwar MM; Khattab M; Elebrashy I; Wafa A; Elhadad H; Awad M; Carapinha JL
    J Med Econ; 2020 Aug; 23(8):908-914. PubMed ID: 32364032
    [No Abstract]   [Full Text] [Related]  

  • 3. Projecting the Potential Budget Impact Analysis of Paliperidone Palmitate in Egyptian Adult Patients with Schizophrenia.
    Elsisi G; Ezzat M; Ramadan M
    J Health Econ Outcomes Res; 2023; 10(2):23-29. PubMed ID: 37600505
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand.
    Rattanavipapong W; Worakijthamrongchai T; Soboon B; Luankongsomchit V; Kongmuangpuk M; Isaranuwatchai W; Teerawattananon Y; Nilanont Y
    BMJ Open; 2022 Sep; 12(9):e064403. PubMed ID: 36167373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt.
    Elsisi GH; Carapinha J; Amin W; Thabet E; Elafify S; Amin M; Hatem A
    J Med Econ; 2019 Oct; 22(10):1047-1054. PubMed ID: 31298593
    [No Abstract]   [Full Text] [Related]  

  • 6. National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.
    Ehlers L; Müskens WM; Jensen LG; Kjølby M; Andersen G
    CNS Drugs; 2008; 22(1):73-81. PubMed ID: 18072816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Low-Dose Compared to Standard-Dose Alteplase for Acute Ischemic Stroke in China: A Within-Trial Economic Evaluation of the ENCHANTED Study.
    Si L; Chen X; Ouyang M; Wang X; Chen G; Cao YJ; Wu G; Zhang J; Zhang J; Liu Y; Zhang S; Song L; Delcourt C; Arima H; Wang L; Lung T; Chen M; Anderson CS; Jan S;
    Cerebrovasc Dis; 2023; 52(2):145-152. PubMed ID: 36044836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of Prostate Cancer Cost in Egypt From a Societal Perspective.
    Elsisi GH; El-Attar MM; Ismaeil SM; El-Shater ME; Kirollos MG; Sedrak AS; Morad H; Abdel-Mohsen H; Abdel-Aziz M; Magdy M; Loutfy O
    Glob J Qual Saf Healthc; 2023 May; 6(2):33-41. PubMed ID: 37333760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Ischemic Stroke (AIS) patient management in French stroke units and impact estimation of thrombolysis on care pathways and associated costs.
    Schmidt A; Heroum C; Caumette D; Le Lay K; Bénard S
    Cerebrovasc Dis; 2015; 39(2):94-101. PubMed ID: 25660476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke.
    Nguyen CP; Lahr MM; van der Zee DJ; van Voorst H; Roos YB; Uyttenboogaart M; Buskens E
    Eur Stroke J; 2023 Sep; 8(3):638-646. PubMed ID: 37641549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients.
    Elsisi GH; Carapinha JL; Afify R; Elmoty MA; Khalaf M
    J Med Econ; 2020 Oct; 23(10):1168-1175. PubMed ID: 32669063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.
    Wang X; Robinson TG; Lee TH; Li Q; Arima H; Bath PM; Billot L; Broderick J; Demchuk AM; Donnan G; Kim JS; Lavados P; Lindley RI; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Thang NH; Wang JG; Woodward M; Anderson CS; Chalmers J;
    JAMA Neurol; 2017 Nov; 74(11):1328-1335. PubMed ID: 28973174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants for a low dose of alteplase and its relationship to a lower intracerebral bleeding risk in acute ischemic stroke.
    Chen J; Li H; Lei H; Fang S; Yuan Q; Chen Y; Chen D; Chen R; Zhang Y; Wei J; Chen G; Chen Z; Liu N; Du HW
    Int J Med Sci; 2022; 19(12):1762-1769. PubMed ID: 36313231
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial and subsequent 3-year cost after hospitalization for first acute ischemic stroke and intracerebral hemorrhage.
    Yousufuddin M; Moriarty JP; Lackore KA; Zhu Y; Peters JL; Doyle T; Jensen KL; Ahmmad EM; Al Ward RY; Al-Zu'bi HM; Sharma UM; Seshadri A; Arumaithurai K; Keenan LR; Bhagra S; Murad MH; Borah BJ
    J Neurol Sci; 2020 Dec; 419():117181. PubMed ID: 33099173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion.
    Ye Z; Zhou T; Zhang M; Zhou J; Xie F; Hill MD; Smith EE; Busse JW; Zhang Y; Liu Y; Wang X; Ma Z; An Z
    CMAJ Open; 2023; 11(3):E443-E450. PubMed ID: 37192770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Dose vs. Standard-Dose Intravenous Alteplase in Bridging Therapy Among Patients With Acute Ischemic Stroke: Experience From a Stroke Center in Vietnam.
    Mai DT; Dao VP; Nguyen VC; Vu DL; Nguyen TD; Vuong XT; Bui QV; Phan HQ; Pham QT; Le HK; Tran AT; Nguyen QA; Dang PD; Nguyen H; Phan HT
    Front Neurol; 2021; 12():653820. PubMed ID: 33897607
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
    Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
    J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.